Longevity Venture Partners
Longevity Venture Partners is an early-stage AgeTech/Silvertech venture fund investing 4-6 Israeli companies per year across healthcare, wellness, and longevity technology, anchored by the CommuniCare Family of Companies and offering portfolio companies U.S. senior care pilot access.
- Company typePrivate
- Founded1984
- HeadquartersJerusalem, Israel
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Longevity Venture Partners does
Longevity Venture Partners (LVP) is an early-stage venture capital firm investing in AgeTech and Silvertech companies serving aging populations and senior care markets. The firm invests approximately 4-6 Israeli companies per year across healthcare, wellness, and longevity technology, with a portfolio spanning medical devices, digital health, AI-driven diagnostics, mental health platforms, fertility technology, and senior care services. LVP operates a $30M fund and maintains an active cross-border investment footprint across Israel, the United States, and Japan.
LVP's core differentiation is its operational pilot model enabled by its anchor backer, the CommuniCare Family of Companies — a major U.S. skilled nursing operator running 96+ facilities across 7 states, employing 14,000+ staff and serving approximately 9,000 residents. Portfolio companies can access CommuniCare facilities as real-world clinical testbeds for product validation and U.S. market entry, addressing a key bottleneck for Israeli healthtech startups seeking American distribution and regulatory evidence. Notable portfolio holdings include Urologic Health, CustoMED, Exero Medical, OutSense, Voxela, Edocate, Antidote Health, Behavidence, Carefull, LemBas, Carefam, SensifAI Health, Maverick AI, FertilAI, Inhouse Health, Brya, and Faireez.
The firm is led by Co-Founders Stephen Rosedale (Chairman) and Ronald Wilheim (Vice-Chairman), with Raissa Hacohen serving as Managing Partner and Dr. Jonathan Ringo, M.D. as General Partner. LVP's business model follows standard venture economics: management fees on committed capital provide operating revenue, while equity ownership in portfolio companies generates returns on exits. The firm targets 1-10 employees and is headquartered in Jerusalem, Israel.
Longevity Venture Partners firmographics
Firmographics- Name
- Longevity Venture Partners
- Legal name
- Longevity Venture Partners
- Website
- https://longevityventurepartners.com
- Company type
- Private
- Founded year
- 1984
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Longevity Venture Partners is an early-stage AgeTech/Silvertech venture fund investing 4-6 Israeli companies per year across healthcare, wellness, and longevity technology, anchored by the CommuniCare Family of Companies and offering portfolio companies U.S. senior care pilot access.
- Ownership category
- akta.pro rank
Longevity Venture Partners industry classification
Industry- Product category
- Venture Capital and Private Equity
- NAICS
- Other Financial Vehicles (52599)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Venture Capital Fundraising Placement (FSAEALAC)
Keywords
Where Longevity Venture Partners is headquartered
LocationHeadquarters
- HQ city
- Jerusalem
- HQ country
- Israel
- HQ region
- Middle East
Offices2 records
Markets served
Longevity Venture Partners business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Venture Capital Returns: The fund generates returns through equity investments in early-stage companies. Returns are realized through portfolio company exits including IPOs, acquisitions, or secondary sales. The fund leverages its commercial ecosystem (CommuniCare Family of Companies) to help portfolio companies succeed and achieve exits.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Longevity Venture Partners product offering
Product offeringCore offering
Longevity Venture Partners is a $30 million early-stage venture capital fund that invests in 4-6 Israeli companies per year operating in the Silvertech, Healthcare, and Wellness sectors. The fund provides portfolio companies with investment capital, industry expertise, access to an international network of experts, and a pilot ecosystem through its parent company CommuniCare Family of Companies for testing, validation, and refinement of their value propositions before scaling in the US market.
Product overview
Longevity Venture Partners is a $30 million early-stage venture capital fund (as of 2025 Guide to AgeTech Funds) that invests in 4-6 Israeli companies per year in the Silvertech, Healthcare, and Wellness sectors. The fund provides investment capital, industry expertise, access to an international network of experts, and a pilot ecosystem through its parent company CommuniCare Family of Companies (96+ skilled nursing, assisted living, and long-term care facilities across seven states). The fund's portfolio includes multiple AI-powered products: Voxela VCare (AI care management with video analysis), OutSense IoT Sensor (toilet-based health monitoring), Urologic Health niu™ System (non-invasive bladder monitoring), CustoMED (AI + 3D printed orthopedic solutions), Exero Medical xBar (post-operative complication detection), Behavidence (mental health monitoring), Carefull (financial monitoring for seniors), Antidote Health (AI telehealth), and Edocate (virtual patient simulation). These portfolio products collectively address eldercare, diagnostics, digital health, and wellness across the aging population.
Differentiator
Problem solved
Functional benefit
Products and services
- Longevity Venture Partners Fund
Companies that use Longevity Venture Partners
Customer profileNamed customers19 records
Segments3 records
Ideal customer profiles2 records
Longevity Venture Partners technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability14 records
Longevity Venture Partners partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- CommuniCare Family of CompaniescoreCommuniCare Family of Companies is Longevity Venture Partners' parent company and core commercial ecosystem. Founded in 1984 by Stephen Rosedale, CommuniCare has grown to over 96 skilled nursing, assisted living, independent living, behavioral health, and long-term care facilities across seven states (Ohio, Indiana, Maryland, Virginia, West Virginia, Pennsylvania, Missouri). CommuniCare employs more than 14,000 employees and serves nearly 9,000 residents and patients. The ecosystem enables portfolio companies to test, validate, and refine their value propositions before scaling in the US market. CommuniCare participates in Longevity's due diligence processes and sits on the investment committee.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Longevity Venture Partners competitors and assessment
Company assessmentDirect peers
- Kizoo Ventures: Early-stage investor focused on rejuvenation biotech and longevity. Comparable thematic overlap on the longevity/aging frontier.
- Welltech Ventures: Global HealthTech and wellness VC. Co-investor alongside Longevity in Behavidence's $4.3M seed round, indicating overlapping HealthTech/AI thesis.
- Primetime Partners: Early- to growth-stage VC fund exclusively focused on AgeTech and the $8T+ economy serving consumers 50+. Most direct thematic comparable to Longevity's Silvertech/aging mandate.
- Generator Ventures: Early-stage VC fund investing in AgeTech / longevity with an accelerator model and operator network. Closest comparable in sub-sector focus and fund stage.
- ReGen Ventures: Early-stage VC investing in longevity, biotech, and AgeTech. Comparable by virtue of overlapping longevity/aging thesis.
- Ziegler Link•Age: Investment-banking and fund-management platform dedicated to senior living and AgeTech. Comparable as a capital allocator in the same Silvertech vertical.
Broad incumbents
- Jerusalem Venture Partners (JVP): Long-standing Israeli VC with deep HealthTech and digital-health investing; Longevity's Managing Partner previously worked at JVP. Comparable as Israel-domiciled VC writing checks in overlapping categories.
- iAngels: Israel-based angel/early-stage VC platform active in digital health. Co-investor in Antidote Health's $22M Series A and broadly comparable Israeli HealthTech deal flow.
- OurCrowd: Israel-based global VC platform investing broadly in tech and digital health. Comparable as an Israel-headquartered VC with HealthTech exposure.
- Hanaco Ventures: Israeli-US VC investing across HealthTech, software, and consumer. Co-investor with Longevity in portfolio company Edocate's $3M seed round.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Longevity Venture Partners social profiles
Digital presenceLongevity Venture Partners financial estimates
Financial estimateRevenue estimate
Valuation estimate
Longevity Venture Partners leadership team
Management profileNumber of profiles
Profiles4 records
Longevity Venture Partners funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Longevity Venture Partners M&A and investment
M&A and investmentM&A
Investments13 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Longevity Venture Partners
What does Longevity Venture Partners do?
Longevity Venture Partners is a $30 million early-stage venture capital fund that invests in 4-6 Israeli companies per year operating in the Silvertech, Healthcare, and Wellness sectors. The fund provides portfolio companies with investment capital, industry expertise, access to an international network of experts, and a pilot ecosystem through its parent company CommuniCare Family of Companies for testing, validation, and refinement of their value propositions before scaling in the US market.
Is Longevity Venture Partners a public or private company?
Longevity Venture Partners is a private company. It is classified as corporate owned and is currently operating.
When was Longevity Venture Partners founded?
Longevity Venture Partners was founded in 1984. It employs 1 to 10 people.
Where is Longevity Venture Partners based?
Longevity Venture Partners is headquartered in Jerusalem, Israel, in the Middle East region.
How does Longevity Venture Partners make money?
One revenue line is on record: venture Capital Returns.
Who are Longevity Venture Partners's main competitors?
Direct peers on record are Kizoo Ventures, Welltech Ventures, Primetime Partners, Generator Ventures, ReGen Ventures and Ziegler Link•Age. Broad incumbents are Jerusalem Venture Partners (JVP), iAngels, OurCrowd and Hanaco Ventures.
Does Longevity Venture Partners have an API?
No public API is recorded for Longevity Venture Partners.
What industry is Longevity Venture Partners in?
Longevity Venture Partners's product category is Venture Capital and Private Equity. Its primary akta.pro industry code is FSAEALAC, Venture Capital Fundraising Placement. Its NAICS code is 52599 and its SIC code is 6282.